Table 3.
Change in vascular function from baseline according to treatment group stratifying by DM status
Variable | No History of DM | History of DM | ||||
---|---|---|---|---|---|---|
Placebo (n=16) | Allopurinol (n=15) | P Value | Placebo (n=25) | Allopurinol (n=23) | P Value | |
Δ uric acid, mg/dl | −0.22±1.35 | −2.74±1.03 | <0.001 | 0.20±1.65 | −3.31±1.24 | <0.001 |
BA-FMD, % Δ | −0.7±4.1 | 1.4±3.9 | 0.26 | 0.7±4.03 | 0.6±4.1 | 0.92 |
NMD, % Δ | −0.8±5.7 | −0.1±7.3 | 0.79 | −1.6±5.2 | 1.8±5.3 | 0.13 |
Value are expressed as absolute change from baseline±SD. BA-FMD % Δ, % change in BA-FMD; NMD % Δ, % change in NMD.